Navin Fluorine: Pick-up in demand from pharma innovators a key watch
Valuation is quite rich and investors should wait for a better opportunity to accumulate this stock
ANUBHAV SAHU OCTOBER 21, 2022 / 12:16 PM IST
Navin Fluorine: Pick-up in demand from pharma innovators a key watch
Highlights Q2 margins weaker but expected to revert as new plants ramp up Project for Honeywell expected to ramp up earlier than anticipated Client audits and new orders improve CDMO revenue visibility Aggregate revenue potential from new projects more than FY22 revenue Navin Fluorine (CMP: Rs 4,419; Market cap: Rs 21,883 crore) has posted a mixed set of numbers in the reporting quarter. While the top-line growth was steady, margins were lower than expected. The highlight of the quarter was the commencement of commercial supplies…
Navin Fluorine: Pick-up in demand from pharma innovators a key watch
By yourbiotech
